Home
MGRX
MGRX News

Latest Mangoceuticals Inc. (MGRX) News on November 28, 2025

Eli Lilly and Novo Nordisk disown Mangoceuticals’ GLP-1RA partnership claim

Pharmaceutical Technology

14 days ago

Eli Lilly and Novo Nordisk disown Mangoceuticals’ GLP-1RA partnership claim

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs

GlobeNewswire

14 days ago

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs

MT Newswires

15 days ago

Market Chatter: Novo Nordisk, Eli Lilly Reject Partnership Claims by Mangoceuticals

Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management

GlobeNewswire

15 days ago

Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management

MT Newswires

5 months ago

Mangoceuticals Files $150 Million Mixed Shelf

Mangoceuticals shares results from field studies on MGX-0024

TipRanks

6 months ago

Mangoceuticals shares results from field studies on MGX-0024

Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu

GlobeNewswire

6 months ago

Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu

MT Newswires

7 months ago

Mangoceuticals to Acquire Smokeless Technology's Intellectual Property

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

GlobeNewswire

7 months ago

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

Mangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness Solutions

ACCESS Newswire

7 months ago

Mangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness Solutions

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

ACCESS Newswire

7 months ago

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada

GlobeNewswire

8 months ago

Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada

GlobeNewswire

9 months ago

Mangoceuticals Announces the Launch of “PeachesRx” - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments

Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution

GlobeNewswire

10 months ago

Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution

Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research

GlobeNewswire

10 months ago

Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation

GlobeNewswire

10 months ago

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

GlobeNewswire

a year ago

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split

GlobeNewswire

a year ago

Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split

Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire

a year ago

Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement

MangoRx Announces Formation of Strategy and Alternatives Committee

GlobeNewswire

a year ago

MangoRx Announces Formation of Strategy and Alternatives Committee

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

GlobeNewswire

a year ago

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

Newsfile

a year ago

Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024

Mangoceuticals announces 1-for-15 reverse stock split

TipRanks

a year ago

Mangoceuticals announces 1-for-15 reverse stock split

MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN

GlobeNewswire

a year ago

MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN

MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions

GlobeNewswire

a year ago

MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions

MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment

GlobeNewswire

a year ago

MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment

Mangoceuticals Second Quarter 2024 Earnings: US$0.092 loss per share (vs US$0.14 loss in 2Q 2023)

Simply Wall St.

a year ago

Mangoceuticals Second Quarter 2024 Earnings: US$0.092 loss per share (vs US$0.14 loss in 2Q 2023)

MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024

GlobeNewswire

a year ago

MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024

MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent

GlobeNewswire

a year ago

MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent

MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide

GlobeNewswire

a year ago

MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide

ACCESSWIRE

a year ago

MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market

MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology

GlobeNewswire

a year ago

MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology

Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access

GlobeNewswire

a year ago

Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access

MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts

GlobeNewswire

a year ago

MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts

MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department

GlobeNewswire

a year ago

MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department

MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets

GlobeNewswire

a year ago

MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

a year ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

a year ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

a year ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

a year ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

a year ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

a year ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

a year ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology

GlobeNewswire

a year ago

MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology

MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies

GlobeNewswire

a year ago

MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies

MangoRx to Introduce “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances

GlobeNewswire

a year ago

MangoRx to Introduce “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances

Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets

GlobeNewswire

a year ago

Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets

MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts

ACCESSWIRE

2 years ago

MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts

MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications

GlobeNewswire

2 years ago

MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications

MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration

GlobeNewswire

2 years ago

MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration

Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement

GlobeNewswire

2 years ago

Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement

Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care

GlobeNewswire

2 years ago

Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care

Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products

GlobeNewswire

2 years ago

Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products

This Mangoceuticals Insider Increased Their Holding In The Last Year

Simply Wall St.

2 years ago

This Mangoceuticals Insider Increased Their Holding In The Last Year

MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment

GlobeNewswire

2 years ago

MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment

MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth

GlobeNewswire

2 years ago

MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth

MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITY

GlobeNewswire

2 years ago

MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITY

MANGORX TO OFFER THE BIG GAME’S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE… SPIRITS

GlobeNewswire

2 years ago

MANGORX TO OFFER THE BIG GAME’S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE… SPIRITS

MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product

GlobeNewswire

2 years ago

MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product

Koss Corporation Releases Second Quarter Results

GlobeNewswire

2 years ago

Koss Corporation Releases Second Quarter Results

Beam Global Receives $1.7M Order from the North Carolina Department of Adult Correction for Sustainable EV Charging Infrastructure Products

GlobeNewswire

2 years ago

Beam Global Receives $1.7M Order from the North Carolina Department of Adult Correction for Sustainable EV Charging Infrastructure Products

15 Cash-Rich Penny Stocks Hedge Funds Are Buying

Insider Monkey

2 years ago

15 Cash-Rich Penny Stocks Hedge Funds Are Buying

GlobeNewswire

2 years ago

Nuvini (Nasdaq: NVNI) Announces Receipt of Notice of Deficiency from Nasdaq Resulting from Previously Announced Departure of Director

GlobeNewswire

2 years ago

MangoRx’s Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11

Genius Group Announces Closing of $8.25 Million Public Offering

GlobeNewswire

2 years ago

Genius Group Announces Closing of $8.25 Million Public Offering

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

2 years ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Is Black Diamond Therapeutics (NASDAQ:BDTX) In A Good Position To Invest In Growth?

Simply Wall St.

2 years ago

Is Black Diamond Therapeutics (NASDAQ:BDTX) In A Good Position To Invest In Growth?

SEC Charges Future FinTech Group CEO Huang With Manipulative Trading

The Wall Street Journal

2 years ago

SEC Charges Future FinTech Group CEO Huang With Manipulative Trading

Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference

GlobeNewswire

2 years ago

Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference

Two companies will attempt the first US moon landings since the Apollo missions a half-century ago

Associated Press Finance

2 years ago

Two companies will attempt the first US moon landings since the Apollo missions a half-century ago

3 Impressive Shipping Stocks Worth Betting on in 2024

Zacks

2 years ago

3 Impressive Shipping Stocks Worth Betting on in 2024

Canaan Secures Follow-On Purchase Orders from Cipher and Stronghold

PR Newswire

2 years ago

Canaan Secures Follow-On Purchase Orders from Cipher and Stronghold

Monthly information related to total number of voting rights and shares composing the share capital - December 31, 2023

GlobeNewswire

2 years ago

Monthly information related to total number of voting rights and shares composing the share capital - December 31, 2023

Meihua International Medical Technologies Co., Ltd. Announces Closing of Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering

PR Newswire

2 years ago

Meihua International Medical Technologies Co., Ltd. Announces Closing of Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering

Allied Gaming & Entertainment Announces Strategic Investment from Elite Fun Entertainment Co.

Business Wire

2 years ago

Allied Gaming & Entertainment Announces Strategic Investment from Elite Fun Entertainment Co.

HIVE Digital Announces Closing of $28.75 Million Bought Deal Private Placement Financing to “HODL” Our Bitcoin Production and Expand Green Mining Footprint

GlobeNewswire

2 years ago

HIVE Digital Announces Closing of $28.75 Million Bought Deal Private Placement Financing to “HODL” Our Bitcoin Production and Expand Green Mining Footprint

CARA's Late-Stage Skin Disease Study Fails, Stock Plummets 49%

Zacks

2 years ago

CARA's Late-Stage Skin Disease Study Fails, Stock Plummets 49%

Investors Aren't Entirely Convinced By Cango Inc.'s (NYSE:CANG) Revenues

Simply Wall St.

2 years ago

Investors Aren't Entirely Convinced By Cango Inc.'s (NYSE:CANG) Revenues

Reuters

2 years ago

Chinese wealth manager Hywin to offer resolution plans after missed payments

Faraday Future Delivers FF 91 2.0 to Long-Time Employee Xiao Ma (Max) at the Company’s Hanford Manufacturing Plant

Business Wire

2 years ago

Faraday Future Delivers FF 91 2.0 to Long-Time Employee Xiao Ma (Max) at the Company’s Hanford Manufacturing Plant

Reuters

2 years ago

Shares of Shanghai Guijiu, connected to wealth manager Hywin, extend slide

Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering

GlobeNewswire

2 years ago

Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering

Reuters

2 years ago

UPDATE 3-China's Hywin hits record low over missed payments amid property woes

Reuters

2 years ago

China's Hywin seeks payment delay on some products amid property woes

MANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT

GlobeNewswire

2 years ago

MANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT

Mangoceuticals Launches MangoRx Mexico Subsidiary, Paving the Way for Over-the-Counter Retail of Erectile Dysfunction Line of Products in Latin America

GlobeNewswire

2 years ago

Mangoceuticals Launches MangoRx Mexico Subsidiary, Paving the Way for Over-the-Counter Retail of Erectile Dysfunction Line of Products in Latin America

GlobeNewswire

2 years ago

Nuvini (Nasdaq: NVNI) and Semantix, Inc. (Nasdaq: STIX) Forge Strategic Partnership to Implement Artificial Intelligence in Nuvini-Owned Companies

Mangoceuticals Selects TRYBE Labs as its Nationwide Blood Collection and Testing Services Provider

GlobeNewswire

2 years ago

Mangoceuticals Selects TRYBE Labs as its Nationwide Blood Collection and Testing Services Provider

Purple Biotech Reports Third Quarter 2023 Financial Results

GlobeNewswire

2 years ago

Purple Biotech Reports Third Quarter 2023 Financial Results

Airgain Expands Distribution into Australasia with Logic Wireless Partnership

Business Wire

2 years ago

Airgain Expands Distribution into Australasia with Logic Wireless Partnership

Mangoceuticals Expands its Men's Health Product Line with Compounded Hair Growth Treatment 'Grow' by MangoRx

ACCESSWIRE

2 years ago

Mangoceuticals Expands its Men's Health Product Line with Compounded Hair Growth Treatment 'Grow' by MangoRx

Associated Press Finance

2 years ago

Homology Medicines: Q3 Earnings Snapshot

Homology Medicines Reports Third Quarter 2023 Financial Results

GlobeNewswire

2 years ago

Homology Medicines Reports Third Quarter 2023 Financial Results

Eyenovia, Inc. (NASDAQ:EYEN) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Eyenovia, Inc. (NASDAQ:EYEN) Q3 2023 Earnings Call Transcript

Associated Press Finance

2 years ago

Acasti: Fiscal Q2 Earnings Snapshot

Acasti Announces Second Quarter 2024 Financial Results and Business Highlights

GlobeNewswire

2 years ago

Acasti Announces Second Quarter 2024 Financial Results and Business Highlights

Creative Media & Community Trust Announces Date for Its Third Quarter 2023 Earnings Release and Conference Call

Business Wire

2 years ago

Creative Media & Community Trust Announces Date for Its Third Quarter 2023 Earnings Release and Conference Call

Akili Reports Third Quarter 2023 Financial Results and Provides Business Update

Business Wire

2 years ago

Akili Reports Third Quarter 2023 Financial Results and Provides Business Update

Clarus (NASDAQ:CLAR) Has Affirmed Its Dividend Of $0.025

Simply Wall St.

2 years ago

Clarus (NASDAQ:CLAR) Has Affirmed Its Dividend Of $0.025

Share on Social Networks: